Mintr Compass
$834.76
REGN · Regeneron Pharmaceuticals
98 Top-Tier · Mid Horizon
98Top-Tier
Price Action71
Business Quality64
Market Confidence68
AI READ as of 2026-08-20
Trading Neutral
  • Recent price movement remains steady without clear direction
  • Conflicting news reports create uncertainty for short term moves
  • Technical indicators show signs of hesitation
Investing Top-Tier
  • The company maintains a solid financial foundation
  • Market perception of the business is improving
  • The healthcare industry provides a stable backdrop for long term operations
Price & Momentum · Trading
Technical
37
Rel. Strength
92
Momentum
85
Proximity
70
Sentiment
79
Business & Value · Investing
Quality
50
Balance Sheet
79
Growth
63
Valuation
—
Analyst
58
Open REGN in Compass →
Ratings current as of 2026-08-19. Price live as of 2026-08-20 14:30 UTC. Algorithmic percentile rankings from historical and delayed data — not investment advice or a recommendation to buy or sell any security. Markets involve risk including loss of principal. Methodology · Terms · Privacy